Type II-NDHs in M. tuberculosis respiration and persistence

结核分枝杆菌呼吸和持久性中的 II-NDH 型

基本信息

  • 批准号:
    8891858
  • 负责人:
  • 金额:
    $ 19.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-01-01 至 2016-12-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Mycobacterium tuberculosis is an acid-fast, human-specific pathogen and is the etiological agent of the respiratory disease tuberculosis (TB). Approximately 2 billion individuals are currently predicted to be latently infected with the tuberce bacillus. During latency, M. tuberculosis exists within host-generated granulomatous lesions in a poorly understood physiological state termed non-replicating persistence (NRP). It is generally thought that specific conditions initially encountered within granulomatous lesions, including oxygen-limitation and nitric oxide, inhibit aerobic respiration and induce the transition of M. tuberculosis into NRP for long-term survival during anaerobic dormancy. Aerobic and anaerobic respiration in M. tuberculosis is mediated in part by NADH dehydrogenases (NDH), enzymes which catalyze the oxidation of NADH to NAD+ with concomitant transfer of electrons to respiratory chain components. M. tuberculosis encodes one type-1 NDH and two type-2 NDHs. Recently, we identified a third predicted type-2 NDH (Rv1812c) that is regulated by determinants/conditions associated with M. tuberculosis persistence. Preliminary investigations described in this application indicate that Rv1812c encodes a type-2 NDH and participates in the resuscitation of M. tuberculosis from anaerobic dormancy. In addition, we provide bioinformatic evidence indicating that Rv1812c possesses unique structural, functional, and expression characteristics that distinguish it from the other two established type-2 NDHs (Ndh and NdhA) produced in M. tuberculosis. The two specific aims proposed in this application will allow us to investigate and compare the activities of the three type-2 NDHs produced in M. tuberculosis, and determine whether Rv1812c is required for M. tuberculosis NRP or its resuscitation from latency in vivo.
 描述(由申请方提供):结核分枝杆菌是一种抗酸的人类特异性病原体,是呼吸道疾病结核病(TB)的病原体。目前预计约有20亿人潜伏感染结核杆菌。在潜伏期,M.结核病存在于宿主产生的肉芽肿性病变中,其生理状态知之甚少,称为非复制持续性(NRP)。一般认为,肉芽肿病变最初遇到的特定条件,包括氧限制和一氧化氮,抑制有氧呼吸并诱导M。结核病转化为NRP,以便在厌氧休眠期间长期存活。好氧呼吸和无氧呼吸在M.结核病部分地由NADH脱氢酶(NDH)介导,所述酶催化NADH氧化成NAD+,伴随着电子转移到呼吸链组分。M.结核病编码一种1型NDH和两种2型NDH。最近,我们发现了第三种预测的2型NDH(Rv 1812 c),其受与M相关的决定因素/条件的调节。结核病持续存在本申请中描述的初步研究表明Rv 1812 c编码2型NDH并参与M.厌氧休眠引起的肺结核此外,我们提供的生物信息学证据表明,Rv 1812 c具有独特的结构,功能和表达特征,将其与M中产生的其他两种已建立的2型NDH(Ndh和NdhA)区分开来。结核本申请中提出的两个具体目标将使我们能够调查和比较M中产生的三种2型NDH的活性。结核病,并确定是否Rv 1812 c所需的M.结核NRP或从体内潜伏期复苏。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

THOMAS C. ZAHRT其他文献

THOMAS C. ZAHRT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('THOMAS C. ZAHRT', 18)}}的其他基金

Francisella - ATII interactions in respiratory tularemia
弗朗西斯菌 - ATII 在呼吸道兔热病中的相互作用
  • 批准号:
    8383387
  • 财政年份:
    2012
  • 资助金额:
    $ 19.13万
  • 项目类别:
2012 Midwest Microbial Pathogenesis Conference (MMPC)
2012年中西部微生物发病机制会议(MMPC)
  • 批准号:
    8400321
  • 财政年份:
    2012
  • 资助金额:
    $ 19.13万
  • 项目类别:
Francisella - ATII interactions in respiratory tularemia
弗朗西斯菌 - ATII 在呼吸道兔热病中的相互作用
  • 批准号:
    8499239
  • 财政年份:
    2012
  • 资助金额:
    $ 19.13万
  • 项目类别:
Role of FHL-mediated formate metabolism in Mycobacterium tuberculosis persistence
FHL介导的甲酸盐代谢在结核分枝杆菌持久性中的作用
  • 批准号:
    8353015
  • 财政年份:
    2012
  • 资助金额:
    $ 19.13万
  • 项目类别:
Role of FHL-mediated formate metabolism in Mycobacterium tuberculosis persistence
FHL介导的甲酸盐代谢在结核分枝杆菌持久性中的作用
  • 批准号:
    8496708
  • 财政年份:
    2012
  • 资助金额:
    $ 19.13万
  • 项目类别:
Francisella tularensis purine auxotrophs as vaccines candidates
土拉弗朗西斯菌嘌呤营养缺陷型作为候选疫苗
  • 批准号:
    7700368
  • 财政年份:
    2008
  • 资助金额:
    $ 19.13万
  • 项目类别:
M. tuberculosis Genes Regulating Persistent Infection
结核分枝杆菌调节持续感染的基因
  • 批准号:
    7257575
  • 财政年份:
    2001
  • 资助金额:
    $ 19.13万
  • 项目类别:
M.tuberculosis Genes Regulating Persistent Infection
结核分枝杆菌调节持续感染的基因
  • 批准号:
    6897448
  • 财政年份:
    2001
  • 资助金额:
    $ 19.13万
  • 项目类别:
TWO-COMPONENT SYSTEMS OF MYCOBACTERIUM TUBERCULOSIS
结核分枝杆菌的双组分系统
  • 批准号:
    6349761
  • 财政年份:
    2001
  • 资助金额:
    $ 19.13万
  • 项目类别:
M.tuberculosis Genes Regulating Persistent Infection
结核分枝杆菌调节持续感染的基因
  • 批准号:
    6632810
  • 财政年份:
    2001
  • 资助金额:
    $ 19.13万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 19.13万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.13万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 19.13万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.13万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 19.13万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 19.13万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.13万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 19.13万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 19.13万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.13万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了